MPE launches English Myeloma and AL Amyloidosis European Clinical Trial Navigator
The tool will help people find out about clinical trials for myeloma, MGUS, SMM and AL amyloidosis
Read More
Tag: myeloma
Research reveals chaotic schedule for myeloma patients
Myeloma diagnosis can take over five months, requiring several medical consultations
Read More
Sanofi’s Sarclisa combination shows positive results in multiple myeloma patients
Sarclisa is a monoclonal antibody which targets a specific epitope on the CD38 receptor on multiple myeloma cells
Read More
GSK’s anti-BCMA drug Blenrep wins US approval
First anti-BCMA therapy to be approved anywhere in the world
Read More
Genmab/Janssen’s Darzalex combo hits the mark in phase 3 study
Subcutaneous formulation of Darzalex in combination with pomalidomide and dexamethasone meets primary endpoint
Read More
NICE u-turn backs use of Darzalex combo for myeloma relapse
Myeloma patients in England are set to gain NHS access to a new second-line treatment combination following a first relapse of the disease.
Read More
Takeda’s Ninlaro approved for NHS use via CDF
Patients in England and Wales will now be able to access Takeda’s myeloma treatment Ninlaro on the NHS, after cost regulators cleared its use through the Cancer Drugs Fund (CDF).
Read More
Myeloma UK trial to test novel myeloma treatment approach
Myeloma UK has launched a nationwide trial aiming to assess the effectiveness of a novel treatment combination that includes Darzalex for patients with genetically-defined high-risk myeloma.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
